Analysis
Bayer Juggles a $2.45 Billion Biotech Bet and a Washington Trade Probe
Bayer’s stock crept back above a closely watched technical threshold on Friday, but the real drama for the German healthcare...
Ocugen’s CFO Bets on Her Own Stock as a Packed Conference Schedule Previews a Pivotal Summer
The clinical calendar is tightening for Ocugen, and the stock is starting to stir in anticipation. Shares closed the week...
Arafura Rare Earths: The July 2 Vote That Could Decide Australia’s First Fully Integrated Rare Earth Mine — and a US Defense Lifeline
Arafura Rare Earths' shareholders gather on July 2 for an extraordinary general meeting that will determine whether Australia’s first fully...
Record Revenue, 40% Rout: Adobe’s Freemium Gamble Leaves Investors Wanting More
Adobe posted its strongest quarterly sales ever, raised its annual outlook, and watched its shares sink to within a whisker...
German Employers Face Tighter Rules as Top Court Rules Parental Leave Protection Resets for Each Period
A landmark ruling from Germany’s Federal Labor Court (BAG) has clarified that the special dismissal protection for workers on parental...
IBM’s Bitter Pill: A Self-Published Study Triggers an 8% Share Price Slide
The week just passed taught IBM a costly lesson in market psychology. The technology giant had spent months burnishing its...
St George Mining Bets Big on Araxá with $60M Raise, Markets Deliver a 9% Blow
The race to secure Western supply chains for critical minerals has drawn a $20 million bet from Hancock Prospecting on...
Cerebras Showcases Its 50-Times-Larger Chip in Singapore as First Earnings Test Approaches
On a conference stage in Singapore, Cerebras Systems chief strategist Andy Hock held up the company’s Wafer Scale Engine —...
Outlook Therapeutics Rallies as July Puts Two Crossroads in Sharp Focus
The stock has more than doubled since late May, but the coming weeks will determine whether that momentum is sustainable...
Netflix Stock: Short-Term Pain, Long-Term Gain as Ad Revenue and Free Cash Flow Take Center Stage
Netflix shares have slipped into technically oversold territory, with the relative strength index hitting 35.4, yet the bulk of Wall...
Don't Miss It
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
